Profile for Eloxx Pharmaceuticals Inc. (ELOX)

$ 4.04   -0.01 (-0.25%) Volume: 52.89k 4:00 PM EST 21-Feb-2020
Business Description:
Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases.
Address: 950 Winter Street, Waltham, MA, USA, 02451
Telephone: +1 781 577-5300 Website: http://www.eloxxpharma.com
Facsimile: N/A Email: [email protected]
Details
CEO: Robert E. Ward
Employees: 29 Market Cap: 161.61m
Issue Type: CS
Auditor: Deloitte & Touche LLP
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1035354
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)